Opinion: The law has to catch up on orphan-designated drugs with multiple uses
The law has to catch up on the 340B drug discount program, writes a pharmacist.
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 722 articles · page 6 of 21 · fetched about 1 hour ago
Opinion: I treated heat stroke at the NYC Marathon. Marathons need to prepare for a climate-changed world
A doctor’s request to marathons: Let’s make evidence-based medical plans — especially for extreme heat.
Read at source →
STAT+: Medicare Advantage plans shift more costs onto seniors in 2027
Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
Top journal’s special issue on women’s health casts spotlight on menopause and pain
"Highlighting a ton of open questions": Top journal's special issue on women's health examines the latest discoveries…
Read at source →
Mistrust in science and a juicy gene-editing lawsuit
Why have so many Americans lost trust in science? And what's the deal with a new gene-editing lawsuit? Find out on this…
Read at source →
As CDC redesigns annual health survey, it removes questions about disabilities
Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.
Read at source →
STAT+: A journey to witness China’s biotech boom up close
Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get…
Read at source →
STAT+: MAHA goes corporate
Health care companies dominate the MAHA Summit, and a look at Trump's watered down effort to lower Medicare drug prices.
Read at source →
STAT+: A major insurer on how it may replicate Medicare’s chronic-care experiment
In this edition of STAT Health Tech: A California insurer on how it may replicate Medicare's tech-enabled chronic-care…
Read at source →
STAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more
A final Medicare rule aimed at lowering prices for doctor-administered drugs applies to only four companies and saves…
Read at source →
Trump administration appeals ruling blocking limits on international student visas
DHS has appealed a court ruling blocking it from restricting how long international students and postdoctoral…
Read at source →
STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
Read at source →
STAT+: Why a Huntington’s patient isn’t fazed by the waning effect of UniQure’s gene therapy
Questions about the durability of an experimental Huntington's disease therapy matter to Wall Street. They matter less…
Read at source →
STAT+: In Shanghai’s ‘Science City,’ China’s ascendant biotechs make their pitch to the world
A small conference with big ambitions mirrors the rapid growth of Chinese biotech, invites comparisons to U.S. biotech…
Read at source →
STAT+: Can a top Republican from a bygone political era fix pharma’s woes in Washington?
In Washington, Eric Cantor will confront bipartisan backlash over rising health care costs.
Read at source →
STAT+: Two key Senate health committees face major shake-ups
Senate committees that handle important health care matters are about to see major GOP turnover. Here's what that means.
Read at source →
Opinion: I studied GLP-1 use in children. The results are reassuring
“Intervening in childhood could save children from decades of irreversible damage,” a transplant surgeon writes of…
Read at source →
Opinion: Claude analyzed my genome in 30 minutes. Now we need standards for the results
In 2009, analyzing Euan Ashley’s whole genome took 30 people and almost a year. In 2026, he writes, Claude did it in 30…
Read at source →
STAT+: Sanofi, Regeneron expand partnership after Dupixent success
Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug…
Read at source →
STAT+: Trump’s watered-down Medicare drug pricing rule saves 96% less than initial proposal
WASHINGTON — The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered…
Read at source →
STAT+: UnitedHealth investor lawsuit moves forward on allegations it ‘manufactured earnings’ to hide declining profits
An investor lawsuit against UnitedHealth Group will move forward after a federal judge declined the company’s motion to…
Read at source →
STAT+: HHS announces new efforts to speed up, expand clinical trials with AI
Federal health officials want to speed up clinical research to compete with countries like China.
Read at source →
U.S. poised to boot legal immigrants from Medicaid, including refugees and sex-trafficking victims
Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of…
Read at source →
STAT+: What health tech leaders are talking about in Washington policy circles
In this edition of AI Prognosis: Dispatches from Health Datapalooza and MAHA Institute Open Data Summit, and other…
Read at source →
STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
An investigational combination therapy from Eli Lilly led to significant weight loss in a mid-stage study, but high…
Read at source →
Rural MAHA followers say Trump hasn’t improved health of their communities, poll finds
About half of rural voters identify with MAHA movement, but most said President Trump’s health care policies have not…
Read at source →
STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader
Beam Therapeutics has filed a lawsuit alleging one of its former scientists stole intellectual property and used it to…
Read at source →STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more
Gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it…
Read at source →
CDC measles death count still lags Pennsylvania’s
Pennsylvania officials count four measles-related deaths this year. The CDC only counts two.
Read at source →
Opinion: America’s biotech race with China must be won at home
“The surest way to secure our biotech lead is to build up our own capabilities,” write Gary Locke and Patrick McHenry.
Read at source →
Kratom and 7-OH should be regulated, experts agree. They’re split on how
Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in…
Read at source →
Opinion: STAT+: What to think about those mice with half-human brains
New research involving giving mice a human cell-based cortex brings to mind “Flowers for Algernon” and “Pinky and the…
Read at source →
STAT+: At MAHA Summit, a grassroots movement goes corporate
Federal officials and health care executives rubbed elbows at the ritzy MAHA Summit, causing some supporters to…
Read at source →
STAT+: Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseas
Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining…
Read at source →
STAT+: PhRMA taps Eric Cantor as new CEO
Eric Cantor, a former GOP House majority leader, is taking the helm of PhRMA at a challenging time for the industry.
Read at source →
STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used…
Read at source →